EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Recurrent FSGS after renal allograft in pediatric patients Risk factors and therapy



Recurrent FSGS after renal allograft in pediatric patients Risk factors and therapy



Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 670A, Sept




(PDF emailed within 1 workday: $29.90)

Accession: 033119116

Download citation: RISBibTeXText



Related references

Recurrent FSGS after renal allograft in pediatric patients Efficacy of plasmapheresis and cyclophosphamide. Pediatric Nephrology 12(7): C73, Sept, 1998

High dose cyclosporin treatment for recurrent FSGS in pediatric renal allografts. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 914A, September, 2001

Risk factors for anemia during erythropoietin therapy among pediatric dialysis patients A North American Pediatric Renal Transplant Cooperative Study report. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 171A, September, 2000

Risk factors for graft loss due to recurrent and de novo diseases after renal transplantation A report from the renal allograft disease registry. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 677A, Sept, 1998

Risk factors for chronic rejection in pediatric renal allograft recipients. Pediatric Nephrology 10(6): 723-727, 1996

Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature. American Journal of Transplantation 5(10): 2565-2569, 2005

Recurrent nephrotic syndrome after renal transplantation in a patient with primary FSGS Successful therapy with immediate plasma exchange. Kidney & Blood Pressure Research 21(2-4): 167, 1998

Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition. Journal of Pediatrics 124(5 PART 1): 703-708, 1994

Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data. Transplantation 72(2): 256-261, 2001

Induction therapy in pediatric renal allograft recipients Improved survival in African-American patients. Pediatric Research 39(4 PART 2): 362A, 1996

Pre-transplant risk factors for renal allograft dysfunction at one year in Indian patients. National Medical Journal of India 14(1): 18-21, 2001

Risk factors for renal allograft survival in patients receiving cyclosporine immunosuppression. Journal of the Formosan Medical Association 99(6): 453-458, 2000

Assessment of risk factors for chronic allograft nephropathy in renal transplant patients. Transplantation Proceedings 35(7): 2634-2636, 2003

Incidence, risk factors, and the impact of allograft pyelonephritis on renal allograft function. Transplant Infectious Disease 18(5): 647-660, 2016

Important risk factors of allograft survival in cadaveric renal transplantation. A study of 426 patients. Annals of Surgery 207(5): 538-548, 1988